AZTherapies
Boston, US · Founded 2011
Biotech
Founders & leadership
KR
Keith R GreenfieldDirector
PR
Peter R ContiDirector
RR
Ronald R TompkinsDirector
DR
David R ElmalehExecutive Officer, Director
JR
John R PorterDirector
Reported raises · per SEC filings
Form D private placements$14.8MraisedSep 2020 · 59 investors · Other
Rule 506(b)$19MraisedJul 2019 · 25 investors · Biotechnology
Rule 506(b)$5.6MraisedMay 2019 · 11 investors · Biotechnology
Rule 506(b)$16.1MraisedOct 2018 · 35 investors · Biotechnology
Rule 506(b)$1.6MraisedDec 2017 · 9 investors · Biotechnology
Rule 506(b)$6.5MraisedNov 2017 · 43 investors · Biotechnology
Rule 506(b)$16.1MraisedFeb 2017 · 41 investors · Biotechnology
Rule 506(b)$6.1MraisedJan 2015 · 15 investors · Pharmaceuticals
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.